A Prescription Written for Weeks

Maybe it started with a bad month. Heartburn that wouldn’t quit, a doctor’s visit, a prescription. The plan sounded simple: a few weeks, then see how things go. Then the refill came, because the heartburn was still there. Then another. Somewhere along the way, a short course became a standing order, and nobody ever sat down and decided it should.

It helps to look at what the labels actually say. Over-the-counter PPIs are meant for a 14-day course, repeated no more often than every 4 months unless a doctor directs otherwise (FDA). One common prescription PPI, omeprazole, is labeled for up to 4 weeks for heartburn and other reflux symptoms, and 4 to 8 weeks for erosive esophagitis, with additional courses considered if symptoms come back. Maintenance of healing is also listed, though the label notes that controlled studies don’t extend beyond 12 months.

How Weeks Become Years

Refills are easy. Reviews take a decision. In a 2022 clinical practice update, the American Gastroenterological Association (AGA) said that every patient taking a PPI should have a regular review of why they’re taking it, with the reason documented, and that this review should be the responsibility of the patient’s primary care provider. The same update notes that PPIs are increasingly being used for conditions where their benefit is less certain.

A 2018 review of international studies found estimates of inappropriate PPI use ranging widely, from 11% to 84%, and concluded that PPIs continue to be overused worldwide. Those figures describe whole populations, not any one person. But they suggest that a prescription with no current reason behind it is not rare.

How a short course can quietly become years.

Some People Really Do Need to Stay On One

This isn’t an argument against PPIs. For some people they are exactly the right medication. The AGA says patients with complicated reflux disease, such as a history of severe erosive esophagitis, an esophageal ulcer, or a peptic stricture, should generally not be considered for stopping. The same goes for people with known Barrett’s esophagus, eosinophilic esophagitis, or idiopathic pulmonary fibrosis, and for people at high risk of upper GI bleeding.

If any of that describes you, the answer to “do I still need this?” may well be yes, and that is a perfectly good outcome of a review.

What the Label Says About Long-Term Use

The same prescription label lists several cautions tied to longer use. Long-term and multiple-daily-dose therapy may be associated with an increased risk of osteoporosis-related fractures. Daily long-term use (for example, longer than 3 years) may lead to poor B12 absorption or B12 deficiency. Low magnesium has been reported, rarely, with prolonged treatment. And PPI therapy may be associated with an increased risk of C. difficile-associated diarrhea.

The AGA is careful about how to read these, and so should we. Its guidance is that the decision to stop a PPI should rest on whether there is still an indication for it, not on worry about side effects alone. That’s exactly why the review matters: it’s the one conversation that weighs both sides.

What a Review Can and Can’t Tell You

That isn’t a gap in anyone’s care. Those questions are simply outside what the guidance is designed to answer. A review can tell you whether acid suppression is still indicated. It generally can’t tell you whether the conditions that make normal acid hurt are improving.

There’s another wrinkle. The AGA notes that people who step down from a long-term PPI may get transient symptoms from rebound acid hypersecretion. When symptoms flare after a change, it can look like proof the medication is still needed, even when part of what you’re feeling may be the rebound.

PPIs and antacids are built to lower acid. They aren’t designed to directly address damaged protective barriers, chronic inflammation, bacterial imbalance, or impaired natural healing. Those four can make ordinary acid hurt, and they’re a separate question from whether you still need the medication.

Questions Worth Asking at Your Next Refill

• What is the specific reason I’m taking this, and is it written in my chart?
• Is this still the right dose? The AGA suggests most people on twice-daily dosing for a chronic condition be considered for stepping down to once daily.
• Do I have a condition, like Barrett’s or severe erosive esophagitis, that means I should stay on it?
• If we try stepping down, what symptoms should I expect, and what’s the plan if they show up?

Where KMAG Fits: Support Alongside the Review

Kiss My Acid Goodbye (KMAG) isn’t a replacement for your medication or for your doctor’s judgment. It’s built around the four things a PPI isn’t: supporting the barrier, inflammation, bacterial balance, and healing of the tissue that takes the exposure. Many customers start KMAG while staying on their PPI as directed, and work with their doctor over time on whether and how to adjust.

• MUCOSAVE (400mg): barrier support. May help support a protective gel layer along the digestive lining. In a 2-month, double-blind, placebo-controlled trial of 118 adults, a formulation containing MUCOSAVE reduced reflux symptom scores by 59.1% compared with placebo.
• ACTIValoe (150mg): esophageal barrier support. A purified aloe vera extract that may help form a soothing barrier along the esophageal lining.
• GUTGARD (150mg): digestive comfort and tissue support. Our blood-pressure-friendly form of DGL, studied in double-blind trials for digestive comfort.
• German Chamomile Extract 10:1 (200mg): anti-inflammatory support for the low-grade irritation that makes a sensitive gut more reactive.

What to Actually Expect

If you have LPR or have been on PPIs for 1+ years, 4 to 6 months is a very normal timeline. Always work with your doctor before changing medications.

What People Are Saying

Individual results vary. Dose changes were made with a doctor.

This is not medical advice. Always consult with your physician before adding new supplements to your routine, especially if you have any diagnosed medical conditions or are currently taking prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Clinical study data referenced applies to individual ingredients in Kiss My Acid Goodbye and not to the formula as a whole. Individual results may vary.